$4.74 Billion is the total value of RTW INVESTMENTS, LP's 67 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 24.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RCKT | ROCKET PHARMACEUTICALS INC | $362,422,448 | +3.1% | 17,687,772 | 0.0% | 7.65% | +14.3% | |
IMCR | Buy | IMMUNOCORE HLDGS PLCads | $316,402,485 | -12.5% | 6,096,387 | +1.1% | 6.68% | -3.0% |
AXSM | Buy | AXSOME THERAPEUTICS INC | $313,777,864 | +1.9% | 4,489,596 | +4.8% | 6.62% | +13.0% |
ALNY | ALNYLAM PHARMACEUTICALS INC | $298,123,410 | -6.8% | 1,683,362 | 0.0% | 6.29% | +3.3% | |
MRTX | Buy | MIRATI THERAPEUTICS INC | $294,836,470 | +82.4% | 6,768,514 | +51.3% | 6.22% | +102.2% |
ARGX | Buy | ARGENX SEsponsored adr | $249,352,278 | +32.7% | 507,195 | +5.2% | 5.26% | +47.0% |
ACAD | Buy | ACADIA PHARMACEUTICALS INC | $241,255,031 | +3.0% | 11,576,537 | +18.3% | 5.09% | +14.1% |
BRKR | Buy | BRUKER CORP | $210,680,097 | -3.7% | 3,381,703 | +14.3% | 4.44% | +6.7% |
RARE | ULTRAGENYX PHARMACEUTICAL IN | $192,691,423 | -22.7% | 5,405,089 | 0.0% | 4.07% | -14.3% | |
PEN | PENUMBRA INC | $162,895,179 | -29.7% | 673,371 | 0.0% | 3.44% | -22.1% | |
PTCT | PTC THERAPEUTICS INC | $162,140,742 | -44.9% | 7,235,196 | 0.0% | 3.42% | -38.9% | |
TMO | THERMO FISHER SCIENTIFIC INC | $146,958,361 | -3.0% | 290,334 | 0.0% | 3.10% | +7.5% | |
MASI | MASIMO CORP | $131,650,906 | -46.7% | 1,501,493 | 0.0% | 2.78% | -40.9% | |
ESTA | ESTABLISHMENT LABS HLDGS INC | $122,387,352 | -28.5% | 2,494,138 | 0.0% | 2.58% | -20.7% | |
NTRA | Buy | NATERA INC | $117,341,398 | -7.7% | 2,651,783 | +1.5% | 2.48% | +2.4% |
VCEL | VERICEL CORP | $110,343,583 | -10.8% | 3,291,873 | 0.0% | 2.33% | -1.1% | |
SAGE | New | SAGE THERAPEUTICS INC | $105,976,340 | – | 5,149,482 | +100.0% | 2.24% | – |
CLDX | CELLDEX THERAPEUTICS INC NEW | $95,307,292 | -18.9% | 3,463,201 | 0.0% | 2.01% | -10.1% | |
PTGX | PROTAGONIST THERAPEUTICS INC | $90,330,774 | -39.6% | 5,415,514 | 0.0% | 1.91% | -33.1% | |
CYTK | CYTOKINETICS INC | $75,835,873 | -9.7% | 2,574,198 | 0.0% | 1.60% | +0.1% | |
AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $73,505,075 | -34.5% | 7,136,415 | +4.8% | 1.55% | -27.4% |
TXG | Buy | 10X GENOMICS INC | $62,698,185 | -23.3% | 1,519,956 | +3.9% | 1.32% | -14.9% |
TSHA | New | TAYSHA GENE THERAPIES INC | $53,382,465 | – | 16,893,185 | +100.0% | 1.13% | – |
TARS | Buy | TARSUS PHARMACEUTICALS INC | $51,190,057 | +11.2% | 2,880,701 | +13.1% | 1.08% | +23.1% |
ORCHESTRA BIOMED HLDGS INC | $49,011,981 | +24.6% | 5,620,640 | 0.0% | 1.03% | +38.1% | ||
INSM | Buy | INSMED INC | $47,093,977 | +123.2% | 1,865,108 | +86.5% | 0.99% | +147.3% |
MRUS | Buy | MERUS N V | $47,083,695 | +70.2% | 1,996,764 | +90.0% | 0.99% | +88.4% |
New | APOGEE THERAPEUTICS INC | $45,637,188 | – | 2,142,591 | +100.0% | 0.96% | – | |
MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $45,197,189 | -11.7% | 309,485 | +39.7% | 0.95% | -2.1% |
RNA | AVIDITY BIOSCIENCES INC | $42,680,854 | -42.5% | 6,689,789 | 0.0% | 0.90% | -36.2% | |
GHRS | Buy | GH RESEARCH PLCordinary shares | $33,437,646 | +29.9% | 3,327,129 | +53.4% | 0.70% | +43.9% |
MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $28,500,000 | +11.8% | 500,000 | 0.0% | 0.60% | +23.9% | ||
ILMN | Sell | ILLUMINA INC | $25,825,800 | -63.4% | 188,125 | -50.0% | 0.54% | -59.4% |
FULC | Sell | FULCRUM THERAPEUTICS INC | $25,835,490 | +29.1% | 5,818,804 | -4.0% | 0.54% | +43.0% |
ALKS | New | ALKERMES PLC | $24,902,935 | – | 889,073 | +100.0% | 0.52% | – |
AXNX | Sell | AXONICS INC | $24,832,370 | -44.4% | 442,487 | -50.0% | 0.52% | -38.4% |
SWAV | New | SHOCKWAVE MED INC | $24,688,400 | – | 124,000 | +100.0% | 0.52% | – |
SCPH | SCPHARMACEUTICALS INC | $23,480,642 | -30.1% | 3,297,843 | 0.0% | 0.50% | -22.7% | |
ROIVANT SCIENCES LTD | $18,135,735 | +15.9% | 1,552,717 | 0.0% | 0.38% | +28.5% | ||
STOK | STOKE THERAPEUTICS INC | $17,298,799 | -62.9% | 4,390,558 | 0.0% | 0.36% | -58.9% | |
New | ALLURION TECHNOLOGIES INC | $14,868,140 | – | 3,457,707 | +100.0% | 0.31% | – | |
GH | GUARDANT HEALTH INC | $14,846,291 | -17.2% | 500,887 | 0.0% | 0.31% | -8.2% | |
PMVP | Sell | PMV PHARMACEUTICALS INC | $14,587,320 | -23.1% | 2,375,785 | -21.6% | 0.31% | -14.7% |
URGN | UROGEN PHARMA LTD | $12,013,071 | +35.4% | 857,464 | 0.0% | 0.25% | +49.7% | |
CUTR | CUTERA INC | $11,116,508 | -60.2% | 1,846,596 | 0.0% | 0.24% | -55.8% | |
MIST | MILESTONE PHARMACEUTICALS IN | $10,093,916 | +8.8% | 3,256,102 | 0.0% | 0.21% | +20.3% | |
ACELYRIN INC | $9,949,413 | -51.3% | 978,310 | 0.0% | 0.21% | -46.0% | ||
IMTX | IMMATICS N.V | $9,785,100 | +0.3% | 845,000 | 0.0% | 0.21% | +10.8% | |
OM | OUTSET MED INC | $8,798,199 | -50.3% | 808,658 | 0.0% | 0.19% | -44.8% | |
MINERALYS THERAPEUTICS INC | $8,769,171 | -44.2% | 922,100 | 0.0% | 0.18% | -38.1% | ||
SYK | New | STRYKER CORPORATION | $7,651,560 | – | 28,000 | +100.0% | 0.16% | – |
RLMD | RELMADA THERAPEUTICS INC | $6,395,505 | +22.0% | 2,131,835 | 0.0% | 0.14% | +35.0% | |
IMUX | Buy | IMMUNIC INC | $6,372,825 | -40.9% | 4,335,255 | +0.9% | 0.13% | -34.6% |
DSGN | Buy | DESIGN THERAPEUTICS INC | $5,930,647 | -39.8% | 2,512,986 | +60.8% | 0.12% | -33.2% |
ACET | ADICET BIO INC | $5,810,817 | -43.6% | 4,241,472 | 0.0% | 0.12% | -37.2% | |
APYX | APYX MEDICAL CORPORATION | $5,687,021 | -36.4% | 1,777,194 | 0.0% | 0.12% | -29.4% | |
DERMTECH INC | $3,914,433 | -44.6% | 2,718,356 | 0.0% | 0.08% | -38.5% | ||
XGN | EXAGEN INC | $3,611,685 | -16.6% | 1,492,432 | 0.0% | 0.08% | -7.3% | |
New | SAGIMET BIOSCIENCES INC | $3,522,438 | – | 400,277 | +100.0% | 0.07% | – | |
VKTX | Sell | VIKING THERAPEUTICS INC | $2,871,558 | -82.3% | 259,400 | -74.1% | 0.06% | -80.3% |
OLK | Sell | OLINK HLDG ABsponsored ads | $2,413,867 | -80.3% | 163,652 | -75.0% | 0.05% | -78.2% |
AKYA | AKOYA BIOSCIENCES INC | $1,573,662 | -37.1% | 338,422 | 0.0% | 0.03% | -31.2% | |
ARYD | ARYA SCIENCES ACQU CORP IVcl a | $1,384,635 | +2.8% | 127,970 | 0.0% | 0.03% | +11.5% | |
New | RAYZEBIO INC | $1,027,860 | – | 46,300 | +100.0% | 0.02% | – | |
New | SIENTRA INC | $845,220 | – | 304,036 | +100.0% | 0.02% | – | |
MIRO | MIROMATRIX MED INC | $583,241 | -25.1% | 445,222 | 0.0% | 0.01% | -20.0% | |
ROCKET PHARMACEUTICALS INC*w exp 09/02/202 | $59,500 | -10.5% | 350,000 | 0.0% | 0.00% | 0.0% | ||
MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -614,838 | -100.0% | -0.04% | – |
BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -1,700,000 | -100.0% | -0.16% | – |
MRVI | Exit | MARAVAI LIFESCIENCES HLDGS I | $0 | – | -1,532,685 | -100.0% | -0.36% | – |
ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -170,000 | -100.0% | -1.11% | – |
HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -1,000,000 | -100.0% | -1.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
MASIMO CORP | 32 | Q3 2023 | 5.8% |
LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
REGENXBIO INC | 30 | Q4 2022 | 10.8% |
AGENUS INC | 29 | Q2 2022 | 9.0% |
PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
ARGENX SE | 26 | Q3 2023 | 5.3% |
VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D/A | 2024-04-17 |
SC 13D/A | 2024-03-01 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.